Ledger.Open graph →
SEC Form D · filed September 29, 2020

Tetragenetics Inc

Offering
$2.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Arlington, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Robert D. Gailus · New York, NYDirectorChristopher Taron · Essex, MADirectorPeter D. Kiener · Potomac, MDDirectorKevin D. O'Brien · Acton, MAExecTheodore Clark · Ithaca, NYExec · DirectorTim A. Prince · MIDDLETON, WIDirectorRobert E. Akridge · SEATTLE, WADirectorDavid Zolty · TEL AVIV, L3DirectorRick D. Carlson · Gainesville, FLExecEllen D. Baron · Boston, MADirectorAlison D. Taunton-Rigby · Lincoln, MADirectorR D. Kahn · Boston, MAExec · DirectorDaniel D. Grau · Arlington, MADirectorDonna A. Katen-Bahensky · MIDDLETON, WIExecJacob P. Moskol · MIDDLETON, WIDirectorBen Friedman · Tel Aviv, L3DirectorMary Schulman · BETHESDA, MDDirectorEllen D. Baron · Boston, MADirectorAlison D. Taunton-Rigby · Lincoln, MADirectorTheodore Clark · Ithace, NYExec · DirectorR D. Kahn · Boston, MAExec · DirectorDaniel D. Grau · Arlington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗